Artelo Biosciences, Inc. ARTL
ARTL
Artelo Biosciences, Inc. GTBP
GT Biopharma, Inc. PTIX
Protagenic Therapeutics, Inc. CARM
Carisma Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. PBM
Psyence Biomedical Ltd. REVB
Revelation Biosciences, Inc. LIPO
Lipella Pharmaceuticals Inc. SPRC
SciSparc Ltd. SLXN
Silexion Therapeutics Ltd.
Artelo Biosciences, Inc. GTBP
GT Biopharma, Inc. PTIX
Protagenic Therapeutics, Inc. CARM
Carisma Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. PBM
Psyence Biomedical Ltd. REVB
Revelation Biosciences, Inc. LIPO
Lipella Pharmaceuticals Inc. SPRC
SciSparc Ltd. SLXN
Silexion Therapeutics Ltd.
Performance
| Periode | ARTL | GTBP | PTIX | CARM | SLRX | PBM | REVB | LIPO | SPRC | SLXN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -71.75 % | -74.63 % | -65.17 % | -90.23 % | -96.13 % | -80.92 % | -61.70 % | -87.81 % | -76.05 % | -79.64 % |
| YTD | -75.08 % | -73.68 % | -82.94 % | -90.21 % | -97.45 % | -93.76 % | -97.28 % | -93.67 % | -81.92 % | -91.66 % |
| 1Y | -71.70 % | -72.46 % | -83.42 % | -88.89 % | -97.17 % | -94.55 % | -94.09 % | -93.51 % | -69.53 % | -93.44 % |
| 3Y | -90.94 % | -97.70 % | -95.05 % | -99.57 % | -99.53 % | -99.98 % | -99.99 % | -99.44 % | -99.64 % | -99.05 % |
| 5Y | -97.10 % | -99.70 % | -99.02 % | -99.83 % | -99.97 % | -99.98 % | -100.00 % | -96.50 % | -99.94 % | -99.05 % |
| 10Y | -99.61 % | -100.00 % | -99.02 % | -99.93 % | -100.00 % | -99.98 % | -100.00 % | -96.50 % | -99.94 % | -99.05 % |
| From the beginning | -99.61 % | -100.00 % | -99.02 % | -99.98 % | -100.00 % | -99.98 % | -100.00 % | -96.50 % | -99.94 % | -99.05 % |